Ferrostatin-1 treatment can significantly increase the protein level of GPX4 in brain tissue after intracerebral hemorrhage and reduce the BBB damage caused by intracerebral hemorrhage (Zhang Z. et al., 2018). This evidence concerns the gene GPX4 and intracerebral hemorrhage.